NCT00264628已完成不适用
An Outpatient, Randomised, Double-blind, Placebo Controlled, Parallel Group Exploratory Study to Evaluate Safety, Tolerability and Efficacy of GW679769 in Patients With Fibromyalgia Syndrome Comorbid With Depression.
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 8
- 主要终点
- Change in Fibromyalgia Impact Questionnaire (FIQ) total score
研究概览
简要总结
The purpose of the study is to investigate safety, tolerability and efficacy of oral GW679769 up to 120 mg dose compared to placebo in patients with ACR(American College of Rheumatology)-defined fibromyalgia, co-morbid with depression.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Change in Fibromyalgia Impact Questionnaire (FIQ) total score
时间窗: throughout study
次要结局
- Effect of GW679769 vs placebo in health-related quality of life outcomes(throughout study)
- Relationship between PK of GW679769 and clinical outcome in patients(throughout study)
- Safety and Tolerability(throughout study)
研究者
相似试验
已完成
2 期
Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)Depressive Disorder, MajorNCT00413023GlaxoSmithKline348
终止
1 期
Cyclophosphamide Drug Interaction Study In Cancer PatientsNausea and Vomiting, Chemotherapy-InducedNCT00334646GlaxoSmithKline25
已完成
2 期
Study Of GW679769 In Major Depressive DisorderDepressive Disorder, MajorMajor Depressive Disorder (MDD)NCT00102492GlaxoSmithKline356
已完成
3 期
A Study To Evaluate The Efficacy And Safety Of A Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR).Rhinitis, Allergic, PerennialNCT00103454GlaxoSmithKline288
已完成
3 期
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR)Rhinitis, Allergic, PerennialNCT00289198GlaxoSmithKline301